Genprex Net Worth

Genprex Net Worth Breakdown

  GNPX
The net worth of Genprex is the difference between its total assets and liabilities. Genprex's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Genprex's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Genprex's net worth can be used as a measure of its financial health and stability which can help investors to decide if Genprex is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Genprex stock.

Genprex Net Worth Analysis

Genprex's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Genprex's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Genprex's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Genprex's net worth analysis. One common approach is to calculate Genprex's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Genprex's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Genprex's net worth. This approach calculates the present value of Genprex's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Genprex's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Genprex's net worth. This involves comparing Genprex's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Genprex's net worth relative to its peers.
To determine if Genprex is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Genprex's net worth research are outlined below:
Genprex is way too risky over 90 days horizon
Genprex has some characteristics of a very speculative penny stock
Genprex appears to be risky and price may revert if volatility continues
Genprex has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (30.86 M) with profit before overhead, payroll, taxes, and interest of 0.
Genprex currently holds about 25.52 M in cash with (24.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.53.
Genprex has a frail financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer
Genprex uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Genprex. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Genprex's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
29th of March 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Genprex's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Genprex is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genprex backward and forwards among themselves. Genprex's institutional investor refers to the entity that pools money to purchase Genprex's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Royal Bank Of Canada2024-06-30
63.0
Vitalstone Financial Llc2024-09-30
10.0
Global Retirement Partners, Llc.2024-09-30
5.0
Jpmorgan Chase & Co2024-06-30
5.0
Signaturefd, Llc2024-06-30
0.0
Brown Brothers Harriman & Co2024-09-30
0.0
Wells Fargo & Co2024-06-30
0.0
Financial Gravity Wealth, Inc.2024-06-30
0.0
Citadel Advisors Llc2024-06-30
0.0
Geode Capital Management, Llc2024-09-30
16.2 K
Vanguard Group Inc2024-09-30
15.3 K
Note, although Genprex's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Genprex's market capitalization trends

The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.51 M.

Market Cap

10.06 Million

Project Genprex's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(3.12)(3.27)
Return On Capital Employed(4.19)(4.40)
Return On Assets(2.89)(3.04)
Return On Equity(4.16)(4.37)
When accessing Genprex's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Genprex's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Genprex's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Genprex's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genprex. Check Genprex's Beneish M Score to see the likelihood of Genprex's management manipulating its earnings.

Evaluate Genprex's management efficiency

Genprex has return on total asset (ROA) of (1.4594) % which means that it has lost $1.4594 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.1888) %, meaning that it created substantial loss on money invested by shareholders. Genprex's management efficiency ratios could be used to measure how well Genprex manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -3.27 in 2024. Return On Capital Employed is likely to drop to -4.4 in 2024. At this time, Genprex's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 49.1 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.7 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 5.43  5.15 
Tangible Book Value Per Share 4.86  4.62 
Enterprise Value Over EBITDA(0.19)(0.20)
Price Book Value Ratio 1.70  1.61 
Enterprise Value Multiple(0.19)(0.20)
Price Fair Value 1.70  1.61 
Enterprise Value5.3 M4.7 M
Effective leadership at Genprex drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Return On Equity
(3.19)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Genprex insiders, such as employees or executives, is commonly permitted as long as it does not rely on Genprex's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Genprex insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Genprex time-series forecasting models is one of many Genprex's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genprex's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Genprex Earnings per Share Projection vs Actual

Genprex Corporate Management

CMA CPACo ControllerProfile
Kalyn DabbsSr MarketingProfile
Suzanne ThorntonJonesSenior QualityProfile
David SchlossSenior ResourcesProfile
William GannonMember AffairsProfile
Mark MDChief OfficerProfile

Additional Tools for Genprex Stock Analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.